… Univariate and multivariate Cox proportional hazard regression analysis was used to
evaluate the effect of relevant patients’ or procedural risk factors for cardiovascular events or AKI …

… The neutrophil to lymphocyte ratio (NLR) is an … that predicts adverse outcomes in
cardiovascular diseases such as stable coronary artery disease, 9 non-STEMI, 7 and STEMI patients. …

… with COVID-19 disease [14–17]. Lymphocyte ratios might represent a clinically useful and
cost-effective tool for risk stratification of cardiovascular disease and mortality in kidney failure. …

… been widely used for many conditions, such as predicting in-hospital mortality in sepsis
patients, outcomes in cardiovascular diseases, and poor prognosis and higher ICU admissions …

… neutrophil-to-lymphocyte ratio was associated with worse clinical outcome and mortality in
patients with coronary artery disease.… the increase in neutrophil-to-lymphocyte ratio with the …

… Several studies have used the neutrophil to lymphocyte ratio (NLR) as a prognostic indicator
for … The NLR is defined as neutrophil count/lymphocyte count. Patients included in the study …

… Cardiovascular disease (CVD) is considered as the main cause of death in end-stage renal
disease (ESRD) patients … companied with a higher risk for CV mortality in this study. The …

… -to-lymphocyte ratio (PLR) are novel biomarkers that may improve risk stratification of patients
… play a role in the pathophysiology of vascular disease and can lead to thromboembolic …

… independently of hypertension, coronary artery disease (CAD), or evidence of other structural
cardiac diseases [1… % of diabetic patients will develop some form of cardiovascular disease …

… between neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with …
-related adverse events (irAEs) and clinical outcomes in cancer patients who had received at …